Sagimet Bioscience a Aktie
WKN DE: A3CPAM / ISIN: US7867001049
13.08.2025 13:39:20
|
Sagimet Biosciences Inc Q2 Loss Increases, But Beats Estimates
(RTTNews) - Sagimet Biosciences Inc (SGMT) reported Loss for its second quarter that increased from the same period last year but beat the Street estimates.
The company's earnings totaled -$10.386 million, or -$0.32 per share. This compares with -$8.118 million, or -$0.25 per share, last year.
Analysts on average had expected the company to earn -$0.5 per share. Analysts' estimates typically exclude special items.
Sagimet Biosciences Inc earnings at a glance (GAAP) :
-Earnings: -$10.386 Mln. vs. -$8.118 Mln. last year. -EPS: -$0.32 vs. -$0.25 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sagimet Biosciences Inc Registered Shs -A-mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Sagimet Biosciences Inc Registered Shs -A-mehr Analysen
Aktien in diesem Artikel
Sagimet Biosciences Inc Registered Shs -A- | 6,20 | 1,64% |
|